Now showing items 1-5 of 5
Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease
(Wiley Subscription Services, Inc., A Wiley Company, 2004-06)
We used positron emission tomography (PET) with (+)-[ 11 C]dihydrotetrabenazine ([+]-[ 11 C]DTBZ) to examine striatal monoaminergic presynaptic terminal density in 20 patients with dementia with Lewy bodies (DLB), 25 with ...
Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography
(John Wiley & Sons, Inc., 1999-06)
We examined the density of striatal presynaptic monoaminergic terminals, using a ligand for the type 2 vesicular monoamine transporter, (+)-[ 11 C]dihydrotetrabenazine, with positron emission tomography in 7 normal control ...
Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography
(Wiley Subscription Services, Inc., A Wiley Company, 1996-12)
We used [ 11 C]dihydrotetrabenazine, a new ligand for the type 2 vesicular monoamine transporter (VMAT2), with positron emission tomography to study striatal monoaminergic presynaptic terminals in 4 patients with multiple ...
Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions
(Wiley Subscription Services, Inc., A Wiley Company, 1996-02)
Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited progressive neurological disorder characterized by neuronal degeneration and reactive gliosis in the cerebellum, brainstem, spinocerebellar tracts, and dorsal ...